NACDS’ engagement leverages bipartisan momentum for pro-patient, pro-pharmacy PBM reform at state and federal levels.
NACDS: Floridians, all Americans deserve better than the current “pharmaceutical benefit manipulation”
The NACDS-authored column previews the policy outlook for the coming year — and what lies ahead for the future of the industry.
It is a two-year anniversary that patients and pharmacies can appreciate. With a unanimous decision on December 10, 2020, the U.S. Supreme Court upheld an Arkansas law that confronts the damaging tactics of prescription-drug middlemen known as pharmacy benefit managers (PBMs). NACDS had submitted an amicus brief in this case, Rutledge, Attorney General of Arkansas v. Pharmaceutical Care Management Association (PCMA).
Continues momentum in Tennessee and nationwide to advance patients’ health, convenience, and savings by confronting PBM tactics.
The National Community Pharmacists Association (NCPA), the American Pharmacists Association (APhA), the National Association of Chain Drug Stores (NACDS), the Oklahoma Pharmacists Association (OPA) and American Pharmacies (APRx) issued the following joint press release today.
NACDS Total Store Expo — “Tomorrow Happens Here” — welcomes NACDS chain and supplier members back to Boston with vibrant conference schedule, opportunities for connection and collaboration.
Last week, NACDS took issue with an op-ed in The Wall Street Journal titled, “In Defense of Pharmacy Benefit Managers (PBMs),” which asserted that “swarms of drug-company lobbyists appear to have united both parties in opposition to [PBMs]” and that PBMs – unreasonably – “are taking the blame for high drug prices.”
The decision offers hope for the ability of pharmacies to continue to meet patients’ needs in Washington State and across the nation.
NACDS insists that comprehensive DIR fee reform now depends on further legislative and regulatory action to improve predictability, fairness, and viability for pharmacies.
